Keyphrases
MicroRNA
100%
Prediction Model
100%
Pathological Complete Response
100%
Risk Score
100%
Hormone Receptor-positive Breast Cancer
100%
Score-based
100%
Response to Neoadjuvant Chemotherapy
100%
Score Model
60%
Validation Set
40%
Disease-free Survival
40%
External Validation
40%
Internal Validation
40%
Breast Cancer
20%
Tumor
20%
Breast Cancer Patients
20%
Hormone Receptor-positive
20%
Nomogram
20%
Clinical Prognosis
20%
Hazard Ratio
20%
Neoadjuvant Chemotherapy
20%
Human Epidermal Growth Factor Receptor 2 (HER2)
20%
Area under the Curve
20%
Progesterone Receptor
20%
Volume Transfer Constant
20%
Ktrans
20%
Nomogram Score
20%
Initial Treatment Strategy
20%
Medicine and Dentistry
Breast Cancer
100%
Hormone Receptor
100%
microRNA
100%
Neoadjuvant Chemotherapy
100%
Disease Free Survival
40%
Neoplasm
20%
Clinician
20%
Hazard Ratio
20%
Progesterone Receptor
20%
Epidermal Growth Factor Receptor 2
20%
Gamma Urogastrone
20%
Biochemistry, Genetics and Molecular Biology
MicroRNA
100%
Hormone Receptor
100%
Disease Free Survival
40%
Epidermal Growth Factor Receptor
20%
Progesterone Receptor
20%
Immunology and Microbiology
Disease Free Survival
100%
Gamma Urogastrone
50%